Thu, July 13, 2023
Wed, July 12, 2023
Tue, July 11, 2023

Asthika Goonewardene Maintained (ALLO) at Strong Buy with Decreased Target to $18 on, Jul 12th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-18-on-jul-12th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Asthika Goonewardene of Truist Securities, Maintained "Allogene Therapeutics, Inc." (ALLO) at Strong Buy with Decreased Target from $20 to $18 on, Jul 12th, 2023.

Asthika has made no other calls on ALLO in the last 4 months.



There are 8 other peers that have a rating on ALLO. Out of the 8 peers that are also analyzing ALLO, 2 agree with Asthika's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Benjamin Burnett of "Stifel" Maintained at Hold with Decreased Target to $7.5 on, Thursday, May 4th, 2023
  • William Pickering of "Bernstein" Initiated at Hold and Held Target at $6 on, Tuesday, March 21st, 2023


These are the ratings of the 6 analyists that currently disagree with Asthika


  • Mark Breidenbach of "Oppenheimer" Initiated at Buy and Held Target at $28 on, Monday, June 26th, 2023
  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $23 on, Tuesday, June 20th, 2023
  • John Newman of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $35 on, Friday, June 16th, 2023
  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $15 on, Monday, June 5th, 2023
  • Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $15 on, Monday, June 5th, 2023
  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $15 on, Thursday, May 4th, 2023